Tag: adamis pharmaceuticals
August 28, 2019
Adamis Pharmaceuticals Provides Launch and Marketing Update
Adamis Pharmaceuticals (NASDAQ:ADMP) has announced a progress report and marketing update for the US launch of SYMJEPI injections. As quoted... January 17, 2019
Adamis’ Commercial Partner Launches SYMJEPI (epinephrine) in the US
Adamis Pharmaceuticals (NASDAQ:ADMP) today announced that its marketing and commercial partner, Sandoz, a Novartis division, has launched SYMJEPI (epinephrine) 0.3 mg...
January 2, 2019
Adamis Submits NDA for New Product
The application was for Adamis’ naloxone pre-filled single dose syringe (PFS) product candidate, as a treatment for opioid overdose. January 2, 2019
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe
Adamis Pharmaceuticals (NASDAQ:ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for... December 6, 2018
Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI
Adamis Pharmaceuticals (NASDAQ:ADMP) today provided a business update announcing the U.S. launch of FDA-approved SYMJEPI (epinephrine) 0.3mg Injection is planned for...
October 7, 2018
5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent
vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 15, 2018